Onderzoeker
Tom Vanden Berghe
- Disciplines:Biofysica, Moleculaire en celbiologie, Laboratoriumgeneeskunde, Microbiologie, Systeembiologie, Plantenbiologie, Medicinale en biomoleculaire chemie
Affiliaties
- Vakgroep Biomedische Moleculaire Biologie (Departement)
Lid
Vanaf1 okt 1999 → Heden
Projecten
1 - 5 of 5
- Onderzoek naar de immunoregulatorische eigenschappen van ferroptose in experimentele kankermodellenVanaf1 nov 2020 → HedenFinanciering: FWO mandaten
- Therapeutische verkenning van loodferroptoseremmers bij multiple sclerose - subsidie 2020Vanaf1 jan 2020 → 30 jun 2021Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Therapeutische verkenning van loodferroptoseremmers bij multiple scleroseVanaf1 jan 2019 → 31 dec 2020Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Gebaseerde nanodeeltjes ferroptose inductie voor de behandeling van neuroblastoma en glioblastomaVanaf1 jan 2019 → 31 dec 2021Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Studie van de in vivo rol van effector caspasen in (patho-)fysiologische modelsystemen.Vanaf1 okt 2007 → 30 sep 2013Financiering: BOF - Andere acties, FWO mandaten
Publicaties
1 - 10 van 104
- Ferroptosis and pyroptosis signatures in critical COVID-19 patients(2023)
Auteurs: Cédric Peleman, Samya Van Coillie, Symen Ligthart, Jan De Waele, Pieter Depuydt, Dominique Benoit, Hannah Schaubroeck, Sven M. Francque, Karolien Dams, Rita Jacobs, et al.
Pagina's: 2066 - 2077 - Caspase inhibition modulates monocyte-derived macrophage polarization in damaged tissues(2023)
Auteurs: Stéphanie Solier, Michele Mondini, Lydia Meziani, Arnaud Jacquel, Catherine Lacout, Tom Vanden Berghe, Yvon Julé, Jean-Claude Martinou, Gérard Pierron, Julie Rivière, et al.
- Apoptotic cell death in disease : current understanding of the NCCD 2023(2023)
Auteurs: Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A Aaronson, John M Abrams, Dieter Adam, Massimiliano Agostini, Patrizia Agostinis, Emad S Alnemri, Lucia Altucci, et al.
Pagina's: 1097 - 1154 - Beyond ferrostatin-1 : a comprehensive review of ferroptosis inhibitors(2023)
Auteurs: Camilla Scarpellini, Greta Klejborowska, Caroline Lanthier, Behrouz Hassannia, Tom Vanden Berghe, Koen Augustyns
Pagina's: 902 - 916 - Molecular mechanisms of nemorosone-induced ferroptosis in cancer cells(2023)
Auteurs: Roberto Fernández-Acosta, Jurgen Caroen, Bartosz Wiernicki, Daniel Alvarez-Alminaque, Johan Van der Eycken, Peter Vandenabeele, Tom Vanden Berghe, Gilberto L. Pardo-Andreu
- RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD(2023)
Auteurs: Hannelore Van Eeckhoutte, Chantal Donovan, Richard Y. Kim, Thomas M. Conlon, Meshal Ansari, Haroon Khan, Ranjith Jayaraman, Nicole G. Hansbro, Yves Dondelinger, Tom Delanghe, et al.
- Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression(2023)
Auteurs: Emily Van San, Angela Debruyne, Geraldine Veeckmans, Yulia Y. Y. Tyurina, Vladimir A. A. Tyurin, Hao Zheng, Sze Men Choi, Koen Augustyns, Geert van Loo, Bernhard Michalke, et al.
Pagina's: 2092 - 2103 - Targeting ferroptosis protects against experimental (multi)organ dysfunction and death(2022)
Auteurs: Samya Van Coillie, Emily Van San, Ines Goetschalckx, Bartosz Wiernicki, Banibrata Mukhopadhyay, Wulf Tonnus, Ria Roelandt, Catalina Dumitrascu, Ludwig Lamberts, Geert Dams, et al.
- Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state(2022)
Auteurs: Farzaneh Ghazavi, Jelle Huysentruyt, Stephanie Kourula, Sofie Martens, Tim Wartewig, Tatyana Divert, Ria Roelandt, Bastian Popper, Andreas Hiergeist, Peter Tougaard, et al.
- Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity(2022)
Auteurs: Bartosz Wiernicki, Sophia Maschalidi, Jonathan Pinney, Sandy Adjemian Catani, Tom Vanden Berghe, Kodi Ravichandran, Peter Vandenabeele
Patenten
1 - 6 van 6
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- Targeting of Interleukin-1 and -18 in treatment of septic shock (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)